VA Awards $32M for In-Vitro Diagnostic Substances to Fisher Scientific Under SAP
Contract Overview
Contract Amount: $32,070 ($32.1K)
Contractor: Fisher Scientific Company L.L.C.
Awarding Agency: Department of Veterans Affairs
Start Date: 2025-02-01
End Date: 2026-01-01
Contract Duration: 334 days
Daily Burn Rate: $96/day
Competition Type: COMPETED UNDER SAP
Number of Offers Received: 2
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: STRECK QC - ORDERING PERIOD 2
Place of Performance
Location: TEMPLE, BELL County, TEXAS, 76504
State: Texas Government Spending
Plain-Language Summary
Department of Veterans Affairs obligated $32,069.7 to FISHER SCIENTIFIC COMPANY L.L.C. for work described as: STRECK QC - ORDERING PERIOD 2 Key points: 1. The Department of Veterans Affairs (VA) awarded a $32.07 million contract for in-vitro diagnostic substances. 2. Fisher Scientific Company L.L.C. secured the contract, which was competed under the Simplified Acquisition Procedures (SAP). 3. The contract spans from February 1, 2025, to January 1, 2026, with a duration of 334 days. 4. This award falls under the 'In-Vitro Diagnostic Substance Manufacturing' product service code. 5. The contract type is Firm Fixed Price, indicating predictable costs for the VA.
Value Assessment
Rating: good
The contract value of $32.07 million appears reasonable for a one-year requirement of in-vitro diagnostic substances, especially given it was competed under SAP. Benchmarking against similar contracts would provide a more precise assessment.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was competed under Simplified Acquisition Procedures (SAP), suggesting a competitive process among eligible vendors. SAP aims to streamline procurement for smaller dollar amounts, potentially leading to efficient price discovery.
Taxpayer Impact: The competitive nature of this award under SAP suggests that taxpayers are likely receiving a fair price for the necessary diagnostic substances.
Public Impact
Ensures continued availability of critical in-vitro diagnostic substances for VA healthcare facilities. Supports the operational needs of VA laboratories across Texas and potentially other locations. Contributes to the efficient diagnosis and treatment of patients within the VA system. Provides a stable supply chain for essential medical testing materials.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for price increases in subsequent ordering periods if competition is not maintained.
- Reliance on a single vendor for a critical supply chain item.
Positive Signals
- Awarded under a competitive process (SAP).
- Firm Fixed Price contract provides cost certainty.
- Clear delivery period and defined scope of work.
Sector Analysis
The healthcare sector, particularly the supply of diagnostic substances, is crucial for patient care. Spending in this area is generally stable, driven by ongoing medical needs. Benchmarks for similar contracts would depend on the specific types and quantities of substances procured.
Small Business Impact
While this contract was competed under SAP, it's unclear if small businesses participated or benefited directly. Future solicitations could explore set-aside opportunities for small businesses within this category.
Oversight & Accountability
The Department of Veterans Affairs is responsible for overseeing this contract to ensure timely delivery and adherence to specifications. The use of SAP implies a streamlined oversight process, but regular performance monitoring is still essential.
Related Government Programs
- In-Vitro Diagnostic Substance Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Supply chain disruption risk
- Potential for price escalation in future contracts
- Limited visibility into specific product mix and unit costs
- Dependence on a single awardee for a critical supply
Tags
in-vitro-diagnostic-substance-manufactur, department-of-veterans-affairs, tx, delivery-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $32,069.7 to FISHER SCIENTIFIC COMPANY L.L.C.. STRECK QC - ORDERING PERIOD 2
Who is the contractor on this award?
The obligated recipient is FISHER SCIENTIFIC COMPANY L.L.C..
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $32,069.7.
What is the period of performance?
Start: 2025-02-01. End: 2026-01-01.
What specific types and quantities of in-vitro diagnostic substances are included in this contract?
The provided data does not specify the exact types and quantities of in-vitro diagnostic substances. This information is crucial for a comprehensive value assessment. Understanding the product mix would allow for a more accurate comparison against market prices and identify potential areas for cost savings or optimization in future procurements.
What was the competitive landscape like during the SAP competition for this contract?
While the data states the contract was 'COMPETED UNDER SAP,' it doesn't detail the number of bidders or the nature of the competition. SAP is designed for smaller purchases, and while it implies competition, the intensity can vary. Understanding if multiple qualified vendors actively bid and presented competitive pricing is key to assessing the effectiveness of the price discovery mechanism.
How does the unit cost of these diagnostic substances compare to commercial equivalents or other government contracts?
A direct unit cost comparison is not possible with the provided data. The total award amount and contract duration are given, but not per-unit pricing for specific substances. To assess value effectively, a detailed breakdown of the procured items and their corresponding prices is needed. This would enable benchmarking against commercial price lists and other federal contracts for similar items.
Industry Classification
NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › In-Vitro Diagnostic Substance Manufacturing
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: COMPETED UNDER SAP
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Solicitation ID: 36C25725N0095
Offers Received: 2
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Address: 300 INDUSTRY DR, PITTSBURGH, PA, 15275
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $32,070
Exercised Options: $32,070
Current Obligation: $32,070
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: 36C25724D0050
IDV Type: IDC
Timeline
Start Date: 2025-02-01
Current End Date: 2026-01-01
Potential End Date: 2026-01-01 00:00:00
Last Modified: 2026-04-02
More Contracts from Fisher Scientific Company L.L.C.
- Handheld Chemical Explosive and Narcotics Analyzers With Raman and Fourier-Transform Infrared (ftir) Spectroscopy — $5.0M (Department of Homeland Security)
- BD Facsflow Sheath Fluid & Facs Sheath Solution W/Surfactant to Support the Laboratories and Offices Across NIH and Sustain Mission Critical Activities for Health and Longevity Mission Critical Research — $46.0K (Department of Health and Human Services)
- In-Vitro Microbiology Testing Supplies Visn 15 - Option Year TWO — $44.7K (Department of Veterans Affairs)
- Ethanol 200 (delivery) — $42.9K (Department of Veterans Affairs)
- Refrigerated General Purpose Centrifuge - NEW Eppendorf 5920 R — $25.0K (Department of Agriculture)
View all Fisher Scientific Company L.L.C. federal contracts →
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)